.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Queensland Health
Johnson and Johnson
Cantor Fitzgerald
Accenture
US Army
McKesson
Fish and Richardson
Citi
Colorcon

Generated: September 19, 2017

DrugPatentWatch Database Preview

Drugs with Dosage: SUSPENSION/DROPS;OPHTHALMIC

« Back to Dashboard
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage
Novartis Pharms Corp
SIMBRINZA
brimonidine tartrate; brinzolamide
SUSPENSION/DROPS;OPHTHALMIC204251-001Apr 19, 2013RXYesYes► Subscribe► Subscribe ► SubscribeSUSPENSION/DROPS;OPHTHALMIC
Novartis Pharms Corp
SIMBRINZA
brimonidine tartrate; brinzolamide
SUSPENSION/DROPS;OPHTHALMIC204251-001Apr 19, 2013RXYesYes► Subscribe► SubscribeY ► SubscribeSUSPENSION/DROPS;OPHTHALMIC
Novartis Pharms Corp
SIMBRINZA
brimonidine tartrate; brinzolamide
SUSPENSION/DROPS;OPHTHALMIC204251-001Apr 19, 2013RXYesYes► Subscribe► SubscribeY ► SubscribeSUSPENSION/DROPS;OPHTHALMIC
Novartis Pharms Corp
NEVANAC
nepafenac
SUSPENSION/DROPS;OPHTHALMIC021862-001Aug 19, 2005RXYesYes► Subscribe► Subscribe ► SubscribeSUSPENSION/DROPS;OPHTHALMIC
Novartis Pharms Corp
NEVANAC
nepafenac
SUSPENSION/DROPS;OPHTHALMIC021862-001Aug 19, 2005RXYesYes► Subscribe► SubscribeY ► SubscribeSUSPENSION/DROPS;OPHTHALMIC
Novartis Pharms Corp
NEVANAC
nepafenac
SUSPENSION/DROPS;OPHTHALMIC021862-001Aug 19, 2005RXYesYes► Subscribe► SubscribeY ► SubscribeSUSPENSION/DROPS;OPHTHALMIC
Novartis Pharms Corp
TOBRADEX ST
dexamethasone; tobramycin
SUSPENSION/DROPS;OPHTHALMIC050818-001Feb 13, 2009RXYesYes► Subscribe► SubscribeY ► SubscribeSUSPENSION/DROPS;OPHTHALMIC
Novartis Pharms Corp
TOBRADEX ST
dexamethasone; tobramycin
SUSPENSION/DROPS;OPHTHALMIC050818-001Feb 13, 2009RXYesYes► Subscribe► SubscribeY ► SubscribeSUSPENSION/DROPS;OPHTHALMIC
Novartis Pharms Corp
TOBRADEX ST
dexamethasone; tobramycin
SUSPENSION/DROPS;OPHTHALMIC050818-001Feb 13, 2009RXYesYes► Subscribe► SubscribeY ► SubscribeSUSPENSION/DROPS;OPHTHALMIC
Bausch And Lomb
BESIVANCE
besifloxacin hydrochloride
SUSPENSION/DROPS;OPHTHALMIC022308-001May 28, 2009RXYesYes► Subscribe► SubscribeY ► SubscribeSUSPENSION/DROPS;OPHTHALMIC
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Cerilliant
US Army
Federal Trade Commission
Daiichi Sankyo
Argus Health
UBS
Farmers Insurance
Express Scripts
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot